7QR-20648-18243
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 480 / MI
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-18
Registered in v-safe
-
2021-04-18
Dose 1 — Pfizer-BioNTech
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-27
-
2021-05-09
Dose 2 — Pfizer-BioNTech
-
2021-05-09
Health check-in — day 0, dose 2Feeling: Poor · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-16
- 2021-05-23
- 2021-06-01
- 2021-06-08
- 2021-06-13
- 2021-06-20
-
2021-08-08
Survey response — 3 months, dose 2MedDRA: Ovarian mass, Pregnancy — Feeling: GoodFree text: PregnancyLarge mass on ovary (currently ruling out Cancer)MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-11-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-18 | Pfizer-BioNTech | |
| 2 | 2021-05-09 | Pfizer-BioNTech |
Free text
Release 9 — 3 months, dose 2
Symptoms: PregnancyLarge mass on ovary (currently ruling out Cancer)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ovarian mass | ✓ | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release